Syros Pharmaceuticals, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Syros Pharmaceuticals, Inc.
CIK #0001556263
EDGAR Form CIK 2011 - 2025
10-K [0001556263]
10-Q [0001556263]
3 [0001556263]
4 [0001556263]
5 [0001556263]
8-K [0001556263]
D [0001556263]
SC 13D [0001556263]
SC 13G [0001556263]
Form 13D/13G Filer Form 13D/13G Subject Filed
Blue Owl Capital Holdings LP Syros Pharmaceuticals Inc [2024-02-14]
Point72 Asset Management LP Syros Pharmaceuticals Inc [2024-01-02]
Samsara Biocapital LP Syros Pharmaceuticals Inc [2023-10-20]
Adage Capital Partners GP LLC Syros Pharmaceuticals Inc [2023-01-25]
Avidity Partners Management LP Syros Pharmaceuticals Inc [2022-09-20]
Deep Track Capital LP Syros Pharmaceuticals Inc [2022-09-19]
Syros Pharmaceuticals Inc TYME Technologies Inc [2022-07-13]
TYME Technologies Inc Syros Pharmaceuticals Inc [2022-07-13]
BlackRock Inc Syros Pharmaceuticals Inc [2022-07-08]
Artal International SCA Syros Pharmaceuticals Inc [2022-02-11]
View All
Form 3/4/5 Subject 2011 - 2025
Simonian Nancy A
Syros Pharmaceuticals, Inc.
Quirk Gerald E
Chee Conley
Haas Jason
Stephens Kristin
Roth David
Akkaraju Srinivas
Young Richard A
Dunsire Deborah
View All
Terms | Privacy | Guide
tony@aum13f.com